Technical feasibility and clinical evaluation of 4D-MRI guided liver SBRT on the MR-linac

医学 医学物理学 放射科 临床研究
作者
A. van de Lindt,B. Nowee,Tomas Janssen,C. Schneider,Peter Remeijer,Vivian W.J. van Pelt,Anja Betgen,Edwin P.M. Jansen,Jan-Jakob Sonke
出处
期刊:Radiotherapy and Oncology [Elsevier BV]
标识
DOI:10.1016/j.radonc.2022.01.009
摘要

Abstract

Purpose

Image-guided stereotactic body radiation therapy (SBRT) is an important local treatment for liver metastases. MRI-guidance enables direct tumor visualization, eliminating fiducial marker implantation. The purpose of this study was to test technical feasibility of our 4D-MRI guided liver SBRT workflow. Additionally, intra-fraction target motion and consequent target-coverage were studied.

Materials&Methods

Patients with liver metastases were included in this sub-study of the prospective UMBRELLA clinical trial. Patients received mid-position (midP) SBRT. The daily adapt-to-position workflow included localization, verification and intra-fraction tumor midP monitoring using 4D-MRI. Technical feasibility was established based on persistence of the treatment protocol, treatment time ≤1 hour, no geographical miss and no unexpected acute toxicity grade >3. All 4D-MRIs were registered to the planning midP-CT and tumor midP and amplitude were calculated. Additionally, delivered target dose was accumulated incorporating the 4D-MRI intra-fraction tumor motion and evaluated with Monte-Carlo error simulations.

Results

20 patients with liver metastases were included and treated with 4D-MRI guided SBRT. Feasibility criteria were met in all-but-one patient. No grade ≥3 acute toxicity was observed. Group mean (M), systematic and random midP-drifts were 2.4mm, 2.6mm and 3.1mm in CC-direction. 4D-MRI tumor CC-amplitudes were reduced compared to the simulation 4D-CT (M=-1.9mm) and decreased during treatment (M=-1.4mm). Dose accumulation showed adquate target-coverage on a population level.

Conclusion

We successfully demonstrated technical feasibility of 4D-MRI guided SBRT in a cohort of 20 patients with liver metastases. However, substantial midposition drifts occurred which stress the need for intra-fraction motion management strategies to further increase the precision of treatment delivery.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zsl发布了新的文献求助10
刚刚
刚刚
annoying发布了新的文献求助10
刚刚
1秒前
科研通AI5应助Larrin采纳,获得10
1秒前
1秒前
李健应助Leeny采纳,获得10
2秒前
传奇3应助光亮的思柔采纳,获得10
2秒前
李爱国应助快乐的访冬采纳,获得10
3秒前
osmanthus应助科研通管家采纳,获得10
3秒前
星辰大海应助科研通管家采纳,获得10
3秒前
小虫学长应助科研通管家采纳,获得10
3秒前
充电宝应助科研通管家采纳,获得10
3秒前
JamesPei应助科研通管家采纳,获得10
3秒前
大模型应助科研通管家采纳,获得10
3秒前
Lucas应助科研通管家采纳,获得10
3秒前
棠真应助科研通管家采纳,获得10
4秒前
桐桐应助科研通管家采纳,获得10
4秒前
ding应助科研通管家采纳,获得10
4秒前
终梦应助科研通管家采纳,获得10
4秒前
orixero应助科研通管家采纳,获得10
4秒前
天天快乐应助科研通管家采纳,获得10
4秒前
华仔应助科研通管家采纳,获得10
4秒前
所所应助科研通管家采纳,获得30
4秒前
zwy应助科研通管家采纳,获得10
4秒前
星辰大海应助科研通管家采纳,获得10
4秒前
今后应助科研通管家采纳,获得10
4秒前
终梦应助科研通管家采纳,获得10
5秒前
小二郎应助科研通管家采纳,获得10
5秒前
5秒前
SYLH应助科研通管家采纳,获得10
5秒前
5秒前
共享精神应助FOODHUA采纳,获得10
5秒前
5秒前
5秒前
5秒前
SYLH应助科研通管家采纳,获得10
5秒前
5秒前
二两白茶发布了新的文献求助10
5秒前
倦鸟归林发布了新的文献求助10
6秒前
高分求助中
Mass producing individuality 600
Разработка метода ускоренного контроля качества электрохромных устройств 500
Chinesen in Europa – Europäer in China: Journalisten, Spione, Studenten 500
Arthur Ewert: A Life for the Comintern 500
China's Relations With Japan 1945-83: The Role of Liao Chengzhi // Kurt Werner Radtke 500
Two Years in Peking 1965-1966: Book 1: Living and Teaching in Mao's China // Reginald Hunt 500
A Combined Chronic Toxicity and Carcinogenicity Study of ε-Polylysine in the Rat 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3824207
求助须知:如何正确求助?哪些是违规求助? 3366533
关于积分的说明 10440913
捐赠科研通 3085735
什么是DOI,文献DOI怎么找? 1697527
邀请新用户注册赠送积分活动 816398
科研通“疑难数据库(出版商)”最低求助积分说明 769610